1. Carl Zeiss Meditec

    0 Comments Leave a Comment

    1-15 of 1875 1 2 3 4 ... 123 124 125 »
    1. Mentioned In 1875 Articles

    2. Total venous nature of retinal deep capillary plexus inferred by continuity of prominent middle limiting membrane sign in optical coherence tomography

      Total venous nature of retinal deep capillary plexus inferred by continuity of prominent middle limiting membrane sign in optical coherence tomography
      ...ch or central, ischemic or non-ischemic) who had undergone SD-OCT imaging (Optovue, Fremont, California, USA; Carl Zeiss Meditec, Dublin, CA; Heidelberg Engineering, Heidelberg, Germany) from January 2015 to May 2020 to ...
      Read Full Article
    3. Peripapillary Microvascularization Analysis Using Swept-Source Optical Coherence Tomography Angiography in Optic Chiasmal Compression

      Peripapillary Microvascularization Analysis Using Swept-Source Optical Coherence Tomography Angiography in Optic Chiasmal Compression
      ... USA). The RNFL thickness was determined using the 200 × 200 protocol optical disc cube with Cirrus software (Carl Zeiss Meditec, Dublin, CA, USA). This protocol provides an average thickness of the RNFL and the thicknes...
      Read Full Article
    4. Examination of Age-Related Retinal Vascular Changes in the Macula Using Optical Coherence Tomography Angiography of the Eyes After Cataract Surgery

      Examination of Age-Related Retinal Vascular Changes in the Macula Using Optical Coherence Tomography Angiography of the Eyes After Cataract Surgery
      ...oya, Japan), OCT (Spectralis HRA 2, Heidelberg Engineering, Heidelberg, Germany), and OCTA (PLEX® Elite 9000, Carl Zeiss Meditec, Jena, Germany). Slit-lamp examination confirmed the absence of inflammation in the anterio...
      Read Full Article
    5. Student becomes teacher: training faster deep learning lightweight networks for automated identification of optical coherence tomography B-scans of interest using a student-teacher framework

      Student becomes teacher: training faster deep learning lightweight networks for automated identification of optical coherence tomography B-scans of interest using a student-teacher framework
      This work explores a student-teacher framework that leverages unlabeled images to train lightweight deep learning models with fewer parameters to perform fast automated detection of optical coherence tomography B-scans of interest. Twenty-seven lightweight models (LWMs) from four families of models were trained on expert-labeled B-scans (70 K) as either abnormal or normal, which established a baseline performance for the models. Then the LWMs were trained from random initialization using a ...
      Read Full Article
    6. Utility of IOLMaster 700 Swept-Source Optical Coherence Tomography in Detecting Macular Disease for Preoperative Cataract Surgery Patients

      Utility of IOLMaster 700 Swept-Source Optical Coherence Tomography in Detecting Macular Disease for Preoperative Cataract Surgery Patients
      ...hwestern Memorial Hospital from January 2017 to June 2017 with biometry conducted by the Zeiss IOLMaster 700 (Carl Zeiss Meditec AG, Jena, Thuringia, Germany) were included in the study (Table 1). The SS-OCT on the IOLMa...
      Read Full Article
    7. Carl Zeiss Meditec Takes Insight Photonics Solutions to Court for Breach of Contract Seeking $150M in Damages

      Carl Zeiss Meditec Takes Insight Photonics Solutions to Court for Breach of Contract Seeking $150M in Damages
      ...DITEC, INC., Civil Action No. Plaintiff, Complaint v. INSIGHT PHOTONICS SOLUTIONS, INC., Defendant. Plaintiff Carl Zeiss Meditec, Inc. ("Zeiss"), by its attorneys, Dorsey Whitney LLP, for its Complaint against Defendant...
      Read Full Article
    8. A Multitask Deep-Learning System to Classify Diabetic Macular Edema for Different Optical Coherence Tomography Devices: A Multicenter Analysis

      A Multitask Deep-Learning System to Classify Diabetic Macular Edema for Different Optical Coherence Tomography Devices: A Multicenter Analysis
      OBJECTIVE Diabetic macular edema (DME) is the primary cause of vision loss among individuals with diabetes mellitus (DM). We developed, validated, and tested a deep learning (DL) system for classifying DME using images from three common commercially available optical coherence tomography (OCT) devices. RESEARCH DESIGN AND METHODS We trained and validated two versions of a multitask convolution neural network (CNN) to classify DME (center-involved DME [CI-DME], non-CI-DME, or absence of ...
      Read Full Article
    9. 1-15 of 1875 1 2 3 4 ... 123 124 125 »
  1. Categories

    1. Applications:

      Art, Cardiology, Dentistry, Dermatology, Developmental Biology, Gastroenterology, Gynecology, Microscopy, NDE/NDT, Neurology, Oncology, Ophthalmology, Other Non-Medical, Otolaryngology, Pulmonology, Urology
    2. Business News:

      Acquisition, Clinical Trials, Funding, Other Business News, Partnership, Patents
    3. Technology:

      Broadband Sources, Probes, Tunable Sources
    4. Miscellaneous:

      Jobs & Studentships, Student Theses, Textbooks
  2. About Carl Zeiss Meditec

    Carl Zeiss Meditec

    Carl Zeiss Meditec.  Ophthalmology Systems.  Carl Zeiss Meditec is an integrated medical technology company with two main areas of business activity.  In the field of ophthalmology we offer complete solutions for treating the four main eye ailments: vision defects (refraction), cataract, glaucoma and retinal disorders. Our products support doctors and patients to diagnose and treat these ailments efficiently and precisely, thus giving both of them clear benefits, not least by offering them a comprehensive disease management solution. The acquisition of Carl Zeiss Surgical has strengthened our leading market and competitive position for devices and systems in ophthalmic surgery.  Furthermore, we have secured an outstanding starting position in the growth market of neuro/ENT surgery. As the world‘s leading provider of surgical microscopes and visualisation solutions for these treatments, we will further expand our footprint in this area through organic growth and strategic expansion into adjacent market segments. In doing so, we want to develop into a solution provider in this area as well.  Carl Zeiss Meditec's medical technology portfolio is rounded off by innovative and promising future technologies such as intraoperative radiation therapy, which allows the targeted treatment of breast cancer and brain cancer during the operation stage itself.

  3. Quotes about Carl Zeiss Meditec

    1. I have come to rely on the Carl Zeiss Meditec brand for consistent and reliable technologies that are at the forefront of innovation and patient care.
      In Carl Zeiss Meditec Introduces New Suite of Ophthalmic Innovations
    2. Mr Taylor has been instrumental in making Meditec one of the leading companies in the field of ophthalmology in the past few years. My sincere thanks are due to him for his effort and dedication. I am pleased that Mr Taylor will continue to support us in the role of independent consultant and that we will be able to draw on his experience in future. Furthermore, I am convinced that we are ideally set with our current team to accelerate the proposed realisation of growth potential of Carl Zeiss Meditec.
      In Carl Zeiss Meditec reorganises management of its strategic business units
    3. Carl Zeiss Meditec received the highest overall Frost & Sullivan Competitive Metrics Score in the recently completed Strategic Analysis of Optical Imaging Technologies in U.S. Clinical Diagnostics Markets.
      In Frost & Sullivan Lauds Carl Zeiss Meditec for Dominating the OCT Market for Ophthalmic Applications